365 related articles for article (PubMed ID: 16960144)
1. The pharmocogenomics of warfarin: closing in on personalized medicine.
Rettie AE; Tai G
Mol Interv; 2006 Aug; 6(4):223-7. PubMed ID: 16960144
[TBL] [Abstract][Full Text] [Related]
2. Warfarin dose and the pharmacogenomics of CYP2C9 and VKORC1 - rationale and perspectives.
Yin T; Miyata T
Thromb Res; 2007; 120(1):1-10. PubMed ID: 17161452
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics of target genes across the warfarin pharmacological pathway.
Lal S; Jada SR; Xiang X; Lim WT; Lee EJ; Chowbay B
Clin Pharmacokinet; 2006; 45(12):1189-200. PubMed ID: 17112295
[TBL] [Abstract][Full Text] [Related]
4. [Application of warfarin pharmacogenetics].
Tomek A; Mat'oska V; Kumstýrfová T; Táborský L
Vnitr Lek; 2009 Jun; 55(6):565-9. PubMed ID: 19662888
[TBL] [Abstract][Full Text] [Related]
5. Genetic influences on the response to warfarin.
Kamali F
Curr Opin Hematol; 2006 Sep; 13(5):357-61. PubMed ID: 16888441
[TBL] [Abstract][Full Text] [Related]
6. [Oral anticoagulation and pharmacogenetics: importance in the clinical setting].
Benusiglio PR; Desmeules J; de Moerloose P; Dayer P
Rev Med Suisse; 2007 Sep; 3(124):2030, 2033-4, 2036. PubMed ID: 17955831
[TBL] [Abstract][Full Text] [Related]
7. Allelic variants in the CYP2C9 and VKORC1 loci and interindividual variability in the anticoagulant dose effect of warfarin in Italians.
Borgiani P; Ciccacci C; Forte V; Romano S; Federici G; Novelli G
Pharmacogenomics; 2007 Nov; 8(11):1545-50. PubMed ID: 18034619
[TBL] [Abstract][Full Text] [Related]
8. Current pharmacogenetic developments in oral anticoagulation therapy: the influence of variant VKORC1 and CYP2C9 alleles.
Oldenburg J; Bevans CG; Fregin A; Geisen C; Müller-Reible C; Watzka M
Thromb Haemost; 2007 Sep; 98(3):570-8. PubMed ID: 17849045
[TBL] [Abstract][Full Text] [Related]
9. Warfarin pharmacogenetics: CYP2C9 and VKORC1 genotypes predict different sensitivity and resistance frequencies in the Ashkenazi and Sephardi Jewish populations.
Scott SA; Edelmann L; Kornreich R; Desnick RJ
Am J Hum Genet; 2008 Feb; 82(2):495-500. PubMed ID: 18252229
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacogenetics of oral anticoagulants: individualized drug treatment for more efficacy and safety].
Loriot MA; Beaune P
Rev Prat; 2007 Jun; 57(12):1281-6. PubMed ID: 17717937
[TBL] [Abstract][Full Text] [Related]
11. [The pharmacogenetics of vitamin K antagonists: still a matter for discussion].
Moreau C; Siguret V; Loriot MA
Rev Med Interne; 2010 May; 31(5):361-8. PubMed ID: 20362363
[TBL] [Abstract][Full Text] [Related]
12. Appraisal of current vitamin K dosing algorithms for the reversal of over-anticoagulation with warfarin: the need for a more tailored dosing regimen.
Sconce EA; Kamali F
Eur J Haematol; 2006 Dec; 77(6):457-62. PubMed ID: 17042764
[TBL] [Abstract][Full Text] [Related]
13. [Warfarin resistance and related pharmacogenetic information].
Takahashi H
Brain Nerve; 2008 Nov; 60(11):1365-71. PubMed ID: 19069171
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics of vitamin K antagonists: useful or hype?
Lippi G; Franchini M; Favaloro EJ
Clin Chem Lab Med; 2009; 47(5):503-15. PubMed ID: 19397481
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a novel CYP2C9 gene mutation and structural bioinformatic protein analysis in a warfarin hypersensitive patient.
Ciccacci C; Falconi M; Paolillo N; Oteri F; Forte V; Novelli G; Desideri A; Borgiani P
Pharmacogenet Genomics; 2011 Jun; 21(6):344-6. PubMed ID: 21451434
[TBL] [Abstract][Full Text] [Related]
16. Warfarin therapy: influence of pharmacogenetic and environmental factors on the anticoagulant response to warfarin.
Siguret V; Pautas E; Gouin-Thibault I
Vitam Horm; 2008; 78():247-64. PubMed ID: 18374198
[TBL] [Abstract][Full Text] [Related]
17. Warfarin dosing and the promise of pharmacogenomics.
Dumas TE; Hawke RL; Lee CR
Curr Clin Pharmacol; 2007 Jan; 2(1):11-21. PubMed ID: 18690851
[TBL] [Abstract][Full Text] [Related]
18. Will there be a role for genotyping in warfarin therapy?
Gandara E; Wells PS
Curr Opin Hematol; 2010 Sep; 17(5):439-43. PubMed ID: 20601874
[TBL] [Abstract][Full Text] [Related]
19. Combined genetic profiles of components and regulators of the vitamin K-dependent gamma-carboxylation system affect individual sensitivity to warfarin.
Vecsler M; Loebstein R; Almog S; Kurnik D; Goldman B; Halkin H; Gak E
Thromb Haemost; 2006 Feb; 95(2):205-11. PubMed ID: 16493479
[TBL] [Abstract][Full Text] [Related]
20. The pharmacogenetics of the response to warfarin in Chinese.
Lam MP; Cheung BM
Br J Clin Pharmacol; 2012 Mar; 73(3):340-7. PubMed ID: 22023024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
